Recursion Corp (RXRX) - Net Profit

Official company branding of Recursion Pharma (RXRX)

The total financial result of Recursion Pharmaceuticals (RXRX) demonstrates current momentum, with the value stabilizing at -0.51. Capital stability is ensured by long-term contracts with pharma giants, which mitigate the impact of market shocks. Digital data processing and laboratory automation are accelerating the release of therapies. Chris Gibson's visionary leadership is systematically scaling the AI platform, strengthening strategic alliances with tech leaders.

RXRX (Recursion) Company Net Income history from 07/04/2022 to 10/29/2026

Analytical breakdowns and data insights for company Recursion Pharma (RXRX)

- price and consensus price forecast:
Stock Quotes Recursion Pharmaceuticals, Inc.|RXRX - Consensus Target
- market capitalization indicators:
Market Capitalization Recursion Corp|RXRX - Total Company Value
- book capitalization data:
Accounting Value of a Share Recursion|RXRX - Company Book Value|Market Capitalization to Book Value recursion.com|RXRX - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Coefficient Recursion Pharmaceuticals|RXRX - Long-Term Debt to Equity|Current Liabilities to Capital Recursion Corp|RXRX - Company Debts|Debt to Book Value Ratio Recursion Corp|RXRX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Recursion|Critical Liquidity Ratio recursion.com
- net income and valuation multiples indicators:
RXRX - Net Profit
Basic company analysis:recursion.com
Mass-produced product of Recursion

Real-time monitoring of net income is critical for an objective assessment of the issuer, as it allows for the daily tracking of financial results and bypasses quarterly reporting delays. By analyzing the profit history of Recursion Pharmaceuticals (RXRX), an investor can discern the balance between organic growth and one-off effects, which is particularly significant for Recursion Pharmaceuticals (RXRX), where capital-intensive robotics for biological research and AI manipulators determine long-term profitability.

Key competitors

Net Income NVIDIA Corp.|Net Income CRWV|Net Profit Nebius Group NV|Company Net Income SoundHound (SOUN)|ZETA (Zeta Global Holdings) - Final Profit|Company Net Income Pagaya Tech PGY|Net Financial Result C3 AI (AI)|Rezolve AI Ltd - Net Profit|Net Financial Result superx.sg SUPX|Ginkgo Corp (DNA) - Company Net Income|Company Net Income Cerence Inc (CRNC)|Company Net Income Sarcos Technology and Robotics|Company Profit VERI (Veritone Corp)|Net Income MIMI (Mint Incorporation)|MLGO (microalgor.com) - Final Profit|Company Net Income Helport AI HPAI|LPSN (LivePerson Inc) - Profit After Tax|QuickLogic Corp. - Net Profit|Final Profit SST (System1, Inc.)|DVLT: Net Profit|ruanyun.net (RYET) - Net Profit|Company Net Income Webus International|MCRP: Final Profit|Company Net Income Cyngn Inc. (CYN)|Net Income connexasports.com YYAI|Net Profit HOLO (MicroCloud Hologram Inc.)|Net Profit infraredcameras.com MSAI|Evaxion - Net Profit|Xiao-I Corp (AIXI) - Net Income|CXAI: Net Profit|Company Net Income Brand Engagement Network Inc. (BNAI)|Net Income GXAI|Net Profit Evogene, Ltd.|Net Income IFBD (Infobird Co., Ltd)|Profit After Payment of Taxes TAOP|Net Profit VSAI (VERSES AI)|Net Financial Result Exscientia PLC (EXAI)|FOXO Technologies Inc. - Net Profit|Vocodia Holdings Corp. (VHAI) - Net Income|ZPTA: Net Profit